A post by @FirstSquawk on X.

Novo Nordisk’s CEO said the company has lost some market share in India after losing exclusivity, while stressing that many customers still prefer its brand on quality grounds. The disclosure puts a number on how much ground the Danish drugmaker is ceding in one of its key emerging markets as copycat competitors enter. Investors will watch whether the share loss proves temporary, with brand loyalty and quality perception cited as the main offsets.